Table 3.
Dabigatran concentrations and activated partial thromboplastin time (aPTT) according to renal function.
| Total | Creatinine clearance |
p Value | ||
|---|---|---|---|---|
| n=316 | ≥30–<50 mL/min | ≥50 mL/min | ||
| n=40 (13%) | n=276 (87%) | |||
| Dose of dabigatran, 150 mg×2/day, n (%) | 57 (18%) | 3 (7.5%) | 54 (20%) | 0.064 |
| Elapsed time after oral administration (min) | 169 (115–300) | 143 (109–266) | 172 (115–306) | 0.35 |
| Plasma concentrations of dabigatran (ng/mL) | 89 (41–165) | 120 (69–219) | 81 (40–152) | 0.009 |
| aPTT (s) | 38.7 (34.4–44.6) | 44.0 (36.2–47.0) | 38.3 (34.3–44.5) | 0.16 |
Values are expressed as median and interquartile range, or number (n) and %.